RDHL logo

RedHill Biopharma (RDHL) Working Capital

Annual Working Capital

-$3.10 M
+$108.45 M+97.22%

December 31, 2023


Summary


Performance

RDHL Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDHLbalance sheetmetrics:

Quarterly Working Capital

-$5.53 M
-$4.39 M-384.66%

June 1, 2024


Summary


Performance

RDHL Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDHLbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

RDHL Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+97.2%-384.7%
3 y3 years-13.2%-384.7%
5 y5 years-106.7%-384.7%

RDHL Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-140.4%+97.2%-172.0%+95.0%
5 y5-year-107.3%+97.2%-106.6%+95.0%
alltimeall time-105.0%+97.2%-106.6%+95.0%

RedHill Biopharma Working Capital History

DateAnnualQuarterly
Jun 2024
-
-$5.53 M(+384.7%)
Dec 2023
-$3.10 M(-97.2%)
-
Jun 2023
-
-$1.14 M(-40.6%)
Mar 2023
-
-$1.92 M(-98.3%)
Dec 2022
-$111.55 M(-1552.1%)
-$111.55 M(+1.0%)
Sep 2022
-
-$110.43 M(+46.9%)
Jun 2022
-
-$75.15 M(+5575.9%)
Mar 2022
-
-$1.32 M(-117.2%)
Dec 2021
$7.68 M(-380.4%)
$7.68 M(+428.7%)
Sep 2021
-
$1.45 M(-92.5%)
Jun 2021
-
$19.32 M(-58.0%)
Mar 2021
-
$46.03 M(-1779.9%)
Dec 2020
-$2.74 M(-106.4%)
-$2.74 M(-110.8%)
Sep 2020
-
$25.30 M(+0.2%)
Jun 2020
-
$25.25 M(-69.8%)
Mar 2020
-
$83.70 M(+96.5%)
Dec 2019
$42.60 M(-8.2%)
$42.60 M(+151.7%)
Sep 2019
-
$16.92 M(-34.7%)
Jun 2019
-
$25.92 M(-30.7%)
Mar 2019
-
$37.40 M(-19.4%)
Dec 2018
$46.41 M
$46.41 M(+26.2%)
Sep 2018
-
$36.77 M(+64.6%)
Jun 2018
-
$22.34 M(-28.0%)
DateAnnualQuarterly
Mar 2018
-
$31.03 M(-22.1%)
Dec 2017
$39.85 M(-36.2%)
$39.85 M(+25.4%)
Sep 2017
-
$31.78 M(-29.4%)
Jun 2017
-
$44.99 M(-21.7%)
Mar 2017
-
$57.47 M(-8.0%)
Dec 2016
$62.46 M(+13.6%)
$62.46 M(+77.2%)
Sep 2016
-
$35.24 M(-18.3%)
Jun 2016
-
$43.16 M(-13.0%)
Mar 2016
-
$49.63 M(-9.8%)
Dec 2015
$55.00 M(+126.3%)
$55.00 M(-10.2%)
Sep 2015
-
$61.23 M(+154.7%)
Jun 2015
-
$24.04 M(-18.3%)
Mar 2015
-
$29.44 M(+21.1%)
Dec 2014
$24.30 M(+138.6%)
$24.30 M(-16.2%)
Sep 2014
-
$28.98 M(+21.6%)
Jun 2014
-
$23.83 M(-36.7%)
Mar 2014
-
$37.65 M(+269.7%)
Dec 2013
$10.19 M(-41.7%)
$10.19 M(-18.9%)
Sep 2013
-
$12.56 M(-7.1%)
Jun 2013
-
$13.53 M(-14.6%)
Mar 2013
-
$15.83 M(-9.5%)
Dec 2012
$17.48 M(-4.0%)
$17.48 M(+34.9%)
Sep 2012
-
$12.96 M(-28.9%)
Dec 2011
$18.22 M
$18.22 M

FAQ

  • What is RedHill Biopharma annual working capital?
  • What is the all time high annual working capital for RedHill Biopharma?
  • What is RedHill Biopharma annual working capital year-on-year change?
  • What is RedHill Biopharma quarterly working capital?
  • What is the all time high quarterly working capital for RedHill Biopharma?
  • What is RedHill Biopharma quarterly working capital year-on-year change?

What is RedHill Biopharma annual working capital?

The current annual working capital of RDHL is -$3.10 M

What is the all time high annual working capital for RedHill Biopharma?

RedHill Biopharma all-time high annual working capital is $62.46 M

What is RedHill Biopharma annual working capital year-on-year change?

Over the past year, RDHL annual working capital has changed by +$108.45 M (+97.22%)

What is RedHill Biopharma quarterly working capital?

The current quarterly working capital of RDHL is -$5.53 M

What is the all time high quarterly working capital for RedHill Biopharma?

RedHill Biopharma all-time high quarterly working capital is $83.70 M

What is RedHill Biopharma quarterly working capital year-on-year change?

Over the past year, RDHL quarterly working capital has changed by -$4.39 M (-384.66%)